These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29478009)

  • 1. New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides.
    Zhai Y; Luo Y; Wu P; Li D
    J Med Genet; 2018 May; 55(5):287-296. PubMed ID: 29478009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b).
    Greenberg B; Yaroshinsky A; Zsebo KM; Butler J; Felker GM; Voors AA; Rudy JJ; Wagner K; Hajjar RJ
    JACC Heart Fail; 2014 Feb; 2(1):84-92. PubMed ID: 24622121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Clinical Trials of Gene Transfer for Heart Failure with Reduced Ejection Fraction.
    Penny WF; Hammond HK
    Hum Gene Ther; 2017 May; 28(5):378-384. PubMed ID: 28322590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.
    Greenberg B; Butler J; Felker GM; Ponikowski P; Voors AA; Desai AS; Barnard D; Bouchard A; Jaski B; Lyon AR; Pogoda JM; Rudy JJ; Zsebo KM
    Lancet; 2016 Mar; 387(10024):1178-86. PubMed ID: 26803443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Type Natriuretic Peptide Inhibits the Expression and Function of SERCA2a in Heart Failure.
    Zhai Y; Chen J; Kan R; Xuan H; Wang C; Li D; Xu T
    Int Heart J; 2024; 65(2):292-299. PubMed ID: 38556337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for heart failure.
    Greenberg B
    J Cardiol; 2015 Sep; 66(3):195-200. PubMed ID: 25818479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.
    Jessup M; Greenberg B; Mancini D; Cappola T; Pauly DF; Jaski B; Yaroshinsky A; Zsebo KM; Dittrich H; Hajjar RJ;
    Circulation; 2011 Jul; 124(3):304-13. PubMed ID: 21709064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting sarcoplasmic reticulum calcium ATPase by gene therapy.
    Gwathmey JK; Yerevanian A; Hajjar RJ
    Hum Gene Ther; 2013 Nov; 24(11):937-47. PubMed ID: 24164241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of brain natriuretic peptide in preload-dependent regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase expression.
    Kögler H; Schott P; Toischer K; Milting H; Van PN; Kohlhaas M; Grebe C; Kassner A; Domeier E; Teucher N; Seidler T; Knöll R; Maier LS; El-Banayosy A; Körfer R; Hasenfuss G
    Circulation; 2006 Jun; 113(23):2724-32. PubMed ID: 16754798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cardiac function after sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a heart failure model induced by chronic myocardial ischaemia.
    Xin W; Li X; Lu X; Niu K; Cai J
    Acta Cardiol; 2011 Feb; 66(1):57-64. PubMed ID: 21446381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.
    Zsebo K; Yaroshinsky A; Rudy JJ; Wagner K; Greenberg B; Jessup M; Hajjar RJ
    Circ Res; 2014 Jan; 114(1):101-8. PubMed ID: 24065463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.
    Jaski BE; Jessup ML; Mancini DM; Cappola TP; Pauly DF; Greenberg B; Borow K; Dittrich H; Zsebo KM; Hajjar RJ;
    J Card Fail; 2009 Apr; 15(3):171-81. PubMed ID: 19327618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a minipig model of chronic ischemic heart failure].
    Xin W; Lu XC; Li XY; Niu K; Cai JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):336-42. PubMed ID: 21624310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of SERCA2a and miR-25-3p/5p in myocardium of rats with heart failure and therapeutic effects of Xiefei Lishui recipe].
    Wu JB; Ye XH; Xian SX; Dong MG
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Feb; 33(2):146-150. PubMed ID: 29931923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure.
    Kawase Y; Ly HQ; Prunier F; Lebeche D; Shi Y; Jin H; Hadri L; Yoneyama R; Hoshino K; Takewa Y; Sakata S; Peluso R; Zsebo K; Gwathmey JK; Tardif JC; Tanguay JF; Hajjar RJ
    J Am Coll Cardiol; 2008 Mar; 51(11):1112-9. PubMed ID: 18342232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.
    Lipskaia L; Chemaly ER; Hadri L; Lompre AM; Hajjar RJ
    Expert Opin Biol Ther; 2010 Jan; 10(1):29-41. PubMed ID: 20078230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in cardiac function after sarcoplasmic reticulum Ca2+-ATPase gene transfer in a beagle heart failure model.
    Mi YF; Li XY; Tang LJ; Lu XC; Fu ZQ; Ye WH
    Chin Med J (Engl); 2009 Jun; 122(12):1423-8. PubMed ID: 19567165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adeno-associated viral gene transfer of SERCA2a improves heart function in chronic congestive heart failure rats].
    Hui HP; Li XY; Liu XH; Sun S; Lu XC; Liu T; Yang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):357-62. PubMed ID: 16776934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.
    Hulot JS; Salem JE; Redheuil A; Collet JP; Varnous S; Jourdain P; Logeart D; Gandjbakhch E; Bernard C; Hatem SN; Isnard R; Cluzel P; Le Feuvre C; Leprince P; Hammoudi N; Lemoine FM; Klatzmann D; Vicaut E; Komajda M; Montalescot G; Lompré AM; Hajjar RJ;
    Eur J Heart Fail; 2017 Nov; 19(11):1534-1541. PubMed ID: 28393439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
    Papolos A; Frishman WH
    Cardiol Rev; 2013; 21(3):151-4. PubMed ID: 23568057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.